Trial site
UCLA Hematology-Oncology
- 12running trials
- 14closed trials
The trials here
What the 26 trials at this site are about, from their registry records.
- Conditions
- Lung cancer8 trials
- Head and neck cancer7 trials
- Bladder cancer6 trials
- Melanoma6 trials
- Metastatic breast cancer5 trials
- Colorectal cancer4 trials
- Kidney cancer4 trials
- Ovarian cancer4 trials
- Pancreatic cancer4 trials
- Prostate cancer3 trials
- Gastric and oesophageal cancer2 trials
- Cervical cancer1 trial
- and 6 more
- Phase
- Phase 312 trials
- Phase 27 trials
- Phase 14 trials
- Phase 1/23 trials
- Status
- Completed8 trials
- Recruiting7 trials
- Terminated6 trials
- Active, not recruiting4 trials
- Not yet recruiting1 trial
- Lead sponsor
- Pfizer8 trials
- Seagen, a wholly owned subsidiary of Pfizer5 trials
- Daiichi Sankyo2 trials
- Regeneron Pharmaceuticals2 trials
- Celgene1 trial
- and 8 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Active, not recruiting
Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer2 recruiting
- Melanoma2 recruiting
- Head and neck cancer1 recruiting
- Kidney cancer1 recruiting
- Lung cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Terminated
Completed
Completed
Terminated
Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma
Terminated
CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
Terminated
Completed
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer
Completed
TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers
Terminated
Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.
Completed
Completed
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026